DFO
ZBH icon

Duquesne Family Office’s Zimmer Biomet ZBH Stock Holding History

Duquesne Family Office’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-125,815
Closed -$14.6M – 82
2020
Q2 		$14.6M Buy
+125,815
New +$14.5M 0.45% 44

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Duquesne Family Office's ZBH Position: Q3 2020 in Review

Duquesne Family Office sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 125,815 shares — an estimated $14.6M sold.

Duquesne Family Office first reported a position in ZBH in Q2 2020 and held it in 1 quarter. The position peaked at $14.6M in Q2 2020. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

  • Duquesne Family Office reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
  • Duquesne Family Office sold 125,815 Zimmer Biomet shares in Q3 2020, an estimated $14.6M.
  • Duquesne Family Office first reported a position in Zimmer Biomet in Q2 2020 and held it in 1 quarter.
  • Duquesne Family Office's Zimmer Biomet position peaked at $14.6M in Q2 2020.
  • 930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Duquesne Family Office's 13F filing for Q3 2020, filed 16 Nov 2020.